W. Yao - Concepedia

Author

W. Yao

Also Known As

W. X. Yao, W. Yao, W.X. Yao, Wanchen Yao, Weijia Yao, Weisheng Yao, Weixun Yao, Wenlian Yao, Winston Yao, Yao, Weisheng

Publications

195

Citations

H-Index

Concepts

All Affiliations

W. Yao is an author at Sichuan Cancer Hospital specializing in medicine, radiation oncology, and cancer therapeutics.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	137
2	Immunology	2	2	52
3	Health Sciences	1	1	65
4	Applied Physiology	1	1	65
5	Exercise Physiology	1	1	65

W. Yao

Publications

137

Citations

H-Index

Page 1

	Year	Citations
Exercise preconditioning upregulates cerebral integrins and enhances cerebrovascular integrity in ischemic rats Yuchuan Ding, J. Li, W. Yao, Acta Neuropathologica Upregulates Cerebral IntegrinsEnhances Cerebrovascular IntegrityCerebrovascular DiseaseCerebral Vascular RegulationNeurovascular Disease	2006	65
LBA4 GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an anti-PDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC) Caicun Zhou, Z. Wang, Yehuan Sun, Annals of Oncology Anti-pdl1 AntibodyMedicineImmunologyPathologyImmune Checkpoint Inhibitor	2020	29
1300P A phase Ib/II trial of AK104 (PD-1/CTLA-4 bispecific antibody) in combination with anlotinib in advanced NSCLC Lin Wu, Bolin Chen, W. Yao, Annals of Oncology Advanced NsclcImmunologyAntibody ScreeningImmune Checkpoint InhibitorAntibody Engineering	2021	23
96O Camrelizumab or placebo plus carboplatin and paclitaxel as first-line treatment for advanced squamous NSCLC (CameL-sq): A randomized, double-blind, multicenter, phase III trial C. Zhou, Shengxiang Ren, J. Chen, Journal of Thoracic Oncology Clinical TherapeuticAdvanced Squamous NsclcMedicinePharmacologyClinical Trials	2021	20

Page 1